https://www.selleckchem.com/products/R406.html
4%), and 16.4% (95% CI 10.1-22.7%), respectively. Limited to studies, in which all patients received routine prophylactic anticoagulation, and the prevalence for VTE, DVT, and PE was 30.1% (95% CI 19.4-40.8%), 27.2% (95% CI 16.5-37.9%), and 18.3% (95% CI 9.8%-26.7%), respectively. The prevalence of DVT was higher in studies with routine screening for all patients, when compared to studies with screening only in clinically suspected patients (47.5% vs. 15.1%, P less then 0.001). Conclusion Critically ill patients with COVID-19 have a high p
Like
Comment
Share
